A novel cancer drug known as EXO-CD24 developed and tested at Tel Aviv Sourasky Medical Center (Ichilov Hospital), demonstrates promising […]
Atlantic Health System is now enrolling hospitalized patients with severe COVID-19 in the PRE-VENT phase 3 multicenter trial of pacritinib, […]
St. David’s Medical Center and St. David’s South Austin Medical Center are enrolling patients in two more studies for medications […]
A clinical trial conducted by Washington University School of Medicine in St. Louis actually evidences the potential that fluvoxamine, an […]
Temple University’s Lewis Katz School of Medicine recently published the results of a study that risk stratifies COVID-19 patients—identifying those […]
Washington University School of Medicine (WUSM) in St. Louis now leads a Phase 3 clinical trial, funded by the National […]
Intermountain Healthcare, a Utah-based healthcare system, is widely recognized as a leader in transforming healthcare by using evidence-based best practices to […]
The Korea Advanced Institute of Science and Technology reports a joint team of researchers discovered the cause of hyper-inflammatory response […]
Four different clinical studies reveal that rheumatoid arthritis drug baricitinib may be effective in preventing cytokine storms—those severe immune system […]
A major push right now to battle COVID-19 concerns not only vaccines, but also antibodies, because these treatments could be […]
